| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.49e-05 | 4 | 32 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.49e-05 | 4 | 32 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.58e-04 | 15 | 32 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.40e-04 | 93 | 32 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 6.72e-04 | 24 | 32 | 2 | GO:0043027 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 6.72e-04 | 24 | 32 | 2 | GO:0120283 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.87e-03 | 40 | 32 | 2 | GO:0019213 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 2.57e-03 | 47 | 32 | 2 | GO:0008375 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 2.91e-03 | 50 | 32 | 2 | GO:0004864 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 3.38e-03 | 54 | 32 | 2 | GO:0019212 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 3.38e-03 | 54 | 32 | 2 | GO:0043028 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 3.50e-03 | 55 | 32 | 2 | GO:0008146 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 4.93e-03 | 435 | 32 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 6.25e-03 | 74 | 32 | 2 | GO:0016782 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 6.26e-03 | 1418 | 32 | 7 | GO:0030234 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 7.45e-03 | 81 | 32 | 2 | GO:0016811 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.89e-07 | 8 | 32 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 5.55e-07 | 11 | 32 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 2.27e-06 | 17 | 32 | 3 | GO:0030202 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 2.15e-05 | 35 | 32 | 3 | GO:0015012 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 1.73e-04 | 70 | 32 | 3 | GO:0030166 | |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 2.21e-04 | 76 | 32 | 3 | GO:0000271 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 2.21e-04 | 76 | 32 | 3 | GO:0006024 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 2.57e-04 | 80 | 32 | 3 | GO:0006023 | |
| Domain | HSNSD | 1.49e-05 | 4 | 30 | 2 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 1.49e-05 | 4 | 30 | 2 | IPR021930 | |
| Domain | BIR | 6.94e-05 | 8 | 30 | 2 | SM00238 | |
| Domain | BIR_REPEAT_2 | 6.94e-05 | 8 | 30 | 2 | PS50143 | |
| Domain | - | 6.94e-05 | 8 | 30 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 6.94e-05 | 8 | 30 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 6.94e-05 | 8 | 30 | 2 | PS01282 | |
| Domain | BIR | 6.94e-05 | 8 | 30 | 2 | PF00653 | |
| Domain | TUDOR | 8.54e-04 | 27 | 30 | 2 | SM00333 | |
| Domain | Tudor | 1.06e-03 | 30 | 30 | 2 | IPR002999 | |
| Domain | Sulfotransferase_dom | 1.52e-03 | 36 | 30 | 2 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.52e-03 | 36 | 30 | 2 | PF00685 | |
| Domain | - | 6.23e-03 | 746 | 30 | 5 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.06e-02 | 848 | 30 | 5 | IPR027417 | |
| Domain | SH2 | 1.14e-02 | 101 | 30 | 2 | PF00017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 7.09e-07 | 11 | 24 | 3 | M47921 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 1.10e-05 | 26 | 24 | 3 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.54e-05 | 29 | 24 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.89e-05 | 31 | 24 | 3 | M685 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 4.43e-05 | 41 | 24 | 3 | M48095 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.02e-04 | 54 | 24 | 3 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.19e-04 | 57 | 24 | 3 | M692 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.77e-04 | 65 | 24 | 3 | MM14911 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 3.72e-04 | 17 | 24 | 2 | M47728 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.93e-04 | 92 | 24 | 3 | M27201 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 5.72e-04 | 21 | 24 | 2 | M47722 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 8.14e-04 | 25 | 24 | 2 | M41829 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.05e-03 | 271 | 24 | 4 | MM15406 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.15e-03 | 123 | 24 | 3 | MM14623 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 1.17e-03 | 30 | 24 | 2 | M41825 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 1.17e-03 | 30 | 24 | 2 | M257 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.23e-03 | 126 | 24 | 3 | M695 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.31e-03 | 288 | 24 | 4 | M16864 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.32e-03 | 129 | 24 | 3 | M186 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.78e-03 | 37 | 24 | 2 | MM15022 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 2.08e-03 | 40 | 24 | 2 | M39695 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 2.29e-03 | 42 | 24 | 2 | M27308 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 8197119 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 22345168 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 18479348 | ||
| Pubmed | 2.82e-06 | 30 | 32 | 3 | 12676797 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 22049073 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 12070138 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 10639137 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 11087757 | ||
| Pubmed | The inhibitors of apoptosis: there is more to life than Bcl2. | 1.72e-05 | 7 | 32 | 2 | 14634619 | |
| Pubmed | The inhibitors of apoptosis (IAPs) and their emerging role in cancer. | 1.72e-05 | 7 | 32 | 2 | 9916987 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 9990849 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 2.29e-05 | 8 | 32 | 2 | 24067353 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 10428862 | ||
| Pubmed | A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships. | 2.94e-05 | 9 | 32 | 2 | 30377379 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 4.49e-05 | 11 | 32 | 2 | 15944372 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 12460940 | ||
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 21652651 | ||
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 7.41e-05 | 14 | 32 | 2 | 29568343 | |
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 1.54e-04 | 20 | 32 | 2 | 17107998 | |
| Pubmed | NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. | 1.87e-04 | 22 | 32 | 2 | 19299468 | |
| Pubmed | The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. | 2.24e-04 | 24 | 32 | 2 | 21822214 | |
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 26554594 | ||
| Pubmed | A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype. | 4.00e-04 | 32 | 32 | 2 | 30926747 | |
| Pubmed | 5.35e-04 | 37 | 32 | 2 | 32201365 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q12 | 1.89e-03 | 92 | 32 | 2 | chr8q12 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 3.58e-05 | 8 | 21 | 2 | 419 | |
| GeneFamily | Sulfotransferases, membrane bound | 8.35e-04 | 37 | 21 | 2 | 763 | |
| GeneFamily | Tudor domain containing | 8.35e-04 | 37 | 21 | 2 | 780 | |
| GeneFamily | SH2 domain containing | 6.05e-03 | 101 | 21 | 2 | 741 | |
| ToppCell | Myeloid-C_(Cd16+_Monocyte)|World / shred on cell class and cell subclass (v4) | 1.92e-06 | 125 | 32 | 4 | c73a77340e79f73fd1f900724e82a94d82e6b1bf | |
| ToppCell | BLOOD--(3)_MNP-(3)_Classical_Mono-1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.19e-06 | 142 | 32 | 4 | 395f80e99be4a0ef07fb9d65c74399e7e67c9a8d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-06 | 182 | 32 | 4 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-06 | 182 | 32 | 4 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 8.90e-06 | 184 | 32 | 4 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 9.69e-06 | 188 | 32 | 4 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 9.89e-06 | 189 | 32 | 4 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 9.89e-06 | 189 | 32 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 1.05e-05 | 192 | 32 | 4 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-05 | 196 | 32 | 4 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | f431f11196dc4332933b5d71c7c7408d54c2dedc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 4b6767bd6fd4bd43eed18fd4a34c20923fa795da | |
| ToppCell | URO-Myeloid|URO / Disease, Lineage and Cell Type | 1.19e-05 | 198 | 32 | 4 | 65a8879da871ddebeda945f312ea7c1065732040 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 18daf83309813f914b17bd226ea8a9269a26b107 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 72c7474e084d1334a09c0a3b0f3c3137038794c8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 1.21e-05 | 199 | 32 | 4 | 3e14f9a62d6414add8d5f681be184b4625001838 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-05 | 199 | 32 | 4 | 126a0ebd40e55c0dfb5e7c7dd8fdd733da6aa323 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 1.21e-05 | 199 | 32 | 4 | 51a766f823a9d50a3b1d59d0df2f5241a6b44c2b | |
| ToppCell | Sepsis-URO-Myeloid|URO / Disease, condition lineage and cell class | 1.24e-05 | 200 | 32 | 4 | 334427a7e1b2b077b1fd33f7ce7d29d823c2f7d6 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.24e-05 | 200 | 32 | 4 | c87d6c59eb4e4118ef151f199b980221918444ae | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Pleural_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.24e-05 | 200 | 32 | 4 | 1798eb621dccb4ccae18d9b3df558a6428d30542 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 200 | 32 | 4 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 200 | 32 | 4 | 47abc2ebf5d6575af59aa044b584acf63a463bbb | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-05 | 200 | 32 | 4 | 6da31ce0a70ad5621444d731c082c0db572c20c5 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 200 | 32 | 4 | 465ed50e0b92bb8c27ffe56d816f063a45b52be9 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 200 | 32 | 4 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 8.05e-05 | 117 | 32 | 3 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-05 | 117 | 32 | 3 | f3c77b234e461566aac81ede0ef84008c9a9f51e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.79e-05 | 125 | 32 | 3 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.23e-04 | 135 | 32 | 3 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l8|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 149 | 32 | 3 | 0f9d2209e8a02371b9f93c0a2fb6f79a4ce48ef1 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 149 | 32 | 3 | 9c4837aa63e46382ff45a41c72beb5722b3ada19 | |
| ToppCell | Myeloid-C_(Monocyte)|World / shred on cell class and cell subclass (v4) | 1.74e-04 | 152 | 32 | 3 | 9145dc014ed7f154c158d454dc2b9754396afcca | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 156 | 32 | 3 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.92e-04 | 157 | 32 | 3 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 161 | 32 | 3 | 3a5f2877e3b29463a3a6da05009b0ab8747b4c47 | |
| ToppCell | Myeloid|World / shred on cell class and cell subclass (v4) | 2.07e-04 | 161 | 32 | 3 | aee407d3739dba2d5216dcdb1579e7e4f483123d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-04 | 162 | 32 | 3 | 88576622af741cf5f754e328bd6d53385ef53be6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-04 | 163 | 32 | 3 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | 1d844d19ff9b49dd0f61f0b24799e172076771ef | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | 9a6abd0e6b11860231ce5e845c87b8d66f3ef697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | 433771abefc5bcb89bdae64af45cce7407bffe5d | |
| ToppCell | PND14-Immune-Immune_Myeloid|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 165 | 32 | 3 | e37d00084f58fbd25f66ee65be510c030167084e | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 32 | 3 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | 69dd747be46e7fbcec571cddd6dee374b9c2507a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 169 | 32 | 3 | c6750c45c44be68aea39e918ba97c6f875ccea34 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 169 | 32 | 3 | 15d5758d94a14a909d1d0c8bba9ce497a33d1512 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-04 | 171 | 32 | 3 | 92cd1d7ec5bc0a77f81b915d237fac4075ba01e3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-04 | 171 | 32 | 3 | 33869b9fab2c94cb33f1cc659073fcf2bb30c22d | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-04 | 172 | 32 | 3 | e72966ced5f2ee9e24ce9fd820d99a69a482a607 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-04 | 172 | 32 | 3 | 83730ea3b240b8e2f2a9fb6c34dd1408050867ff | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 173 | 32 | 3 | 6d29e142d043dfd1ed442812358ac463b63b5e3f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-04 | 175 | 32 | 3 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-04 | 175 | 32 | 3 | a8b05972e1bec4de73feaa6c4a9bcbe6b50c8044 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.73e-04 | 177 | 32 | 3 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 179 | 32 | 3 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-04 | 179 | 32 | 3 | 2832a9ea1c84b809f4bb5fb39d7ad50af4b33fa9 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-04 | 180 | 32 | 3 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.87e-04 | 180 | 32 | 3 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | 08bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 182 | 32 | 3 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 182 | 32 | 3 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.96e-04 | 182 | 32 | 3 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.01e-04 | 183 | 32 | 3 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.01e-04 | 183 | 32 | 3 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-04 | 183 | 32 | 3 | 62f76907e501bba6e1010b5c447faed5f0ef93a7 | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.01e-04 | 183 | 32 | 3 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-04 | 184 | 32 | 3 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-04 | 185 | 32 | 3 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 3.11e-04 | 185 | 32 | 3 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 3.16e-04 | 186 | 32 | 3 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-04 | 187 | 32 | 3 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | 085b61dfad373e5c39f2496539fbfed1b588115a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.26e-04 | 188 | 32 | 3 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.26e-04 | 188 | 32 | 3 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.31e-04 | 189 | 32 | 3 | e4b2f00cb3675a4d94e8807d6ff99cc55f9ed233 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.36e-04 | 190 | 32 | 3 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.36e-04 | 190 | 32 | 3 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.36e-04 | 190 | 32 | 3 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 3.36e-04 | 190 | 32 | 3 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 191 | 32 | 3 | a898153490fb9e8c4331c5dce63dbfb5185bccf2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-04 | 191 | 32 | 3 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.36e-06 | 196 | 31 | 5 | 5461_UP | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 6.69e-06 | 198 | 31 | 5 | 7437_UP | |
| Drug | NSC-725021 | 2.68e-05 | 6 | 31 | 2 | CID000406741 | |
| Disease | azoospermia (implicated_via_orthology) | 3.45e-04 | 27 | 30 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 4.27e-04 | 30 | 30 | 2 | DOID:0050908 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.91e-04 | 152 | 30 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | response to opioid | 1.76e-03 | 61 | 30 | 2 | EFO_0008541 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.88e-03 | 63 | 30 | 2 | DOID:0050866 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDPWKEHAKWFPKCE | 211 | Q13075 | |
| IQVKPTCKPSWQGWN | 236 | Q9BQT9 | |
| EQENDWWVCKHIKKP | 126 | O15143 | |
| PLQGQLWHHWCKKDK | 1271 | Q7Z2Y8 | |
| VHCWWDCKLVQPLWK | 1141 | O00370 | |
| EKPENDPEWWKCKNA | 226 | O43639 | |
| EVENWCPHLPWRAKN | 191 | Q09328 | |
| SKPWQKAWCVIPKQD | 656 | Q96M96 | |
| DKNCPAHWLAQDWER | 791 | Q86TH1 | |
| LWQNPCDDKRHKDIW | 571 | Q9H3R1 | |
| WPCKSKEEWNEIRHQ | 566 | Q8IZ21 | |
| QKCPLAWQSKWEGPE | 4121 | Q8NCM8 | |
| LWNCDKPLPAKHRWP | 516 | Q16394 | |
| LANWKPKEDPWEQHA | 46 | Q96P09 | |
| VQWHPEKAPYEWKNL | 241 | Q92820 | |
| VPIAKKWCANPDWIH | 236 | Q9NQR9 | |
| LCWEPWQPGLHINQK | 251 | Q99062 | |
| CISPKPQKPWDKDAW | 226 | P07948 | |
| QVKHWPSEQDPEKAW | 31 | Q96NZ9 | |
| HPDLPLWCQPWKQHS | 771 | Q9BVI0 | |
| QPFHLNWAWICLEKE | 1766 | P0C091 | |
| DVWQGLRHQPWKQLC | 216 | Q6KF10 | |
| QWCNVVRWEFKHPQP | 1146 | P07814 | |
| ELEEAHQKCPPWWYK | 536 | P35499 | |
| IVPKWHEKPYEWNQV | 1336 | Q8NDG6 | |
| KEVCHPEQANLKWPW | 396 | Q9NTG1 | |
| TNDICWAKVWPDLPN | 1326 | P14410 | |
| PVPVNWKCPWCKAIN | 676 | A0A0J9YY54 | |
| HCVEKPLNNPWHWTA | 296 | O15393 | |
| WQNPCDDKRHKDIWS | 581 | P52849 | |
| EQQEWKIPPCISNWK | 241 | Q13573 | |
| KWFVPWGPNHCDKIR | 61 | Q5T9L3 | |
| KWPGWTHGPLDQKNC | 226 | Q9UJW2 |